|
|
|
Stem Cell Related Patent Number US6709864
| Title: | Adipogenic differentiation of human mesenchymal stem cells | | Inventors: | Pittenger, Mark F.; Severna Park, MD, USA
Beck, Stephen C.; Reistertown, MD, USA | | Summary: | Described herein is a composition for producing adipocytes, comprised of isolated human mesenchymal stem cells in a biocompatible matrix. The invention relates to a composition which induces cells from the mesenchymal stem cell population to differentiate into the adipogenic lineage, and a process for inducing such differentiation. Further disclosed are constituents of the composition, including a glucocorticoid, a compound which stimulates cAMP production or inhibits cAMP degradation such as a phosphodiesterase inhibitor, and a compound which upregulates peroxisome proliferator activated receptor gamma (PPAR gamma) expression and increases its binding affinity to its DNA binding site. A process for isolating the adipocytes from remaining hMSCs is provided, as are therapeutic applications in the production of adipocytes for implantation into a patient for tissue augmentation following trauma or cosmetic surgery. | | Abstract: | A composition which comprises human mesenchymal stem cells which have the potential to differentiate into cells of more than one connective tissue type and a composition which induces cells from the mesenchymal stem cell population to differentiate into the adipogenic lineage, and a process for inducing such differentiation. The composition for inducing such differentiation comprises a glucocorticoid, a compound which stimulates cAMP production or inhibits cAMP degradation (such as a phosphodiesterase inhibitor), and/or a compound which upregulates peroxisome proliferator activated receptor .gamma. (PPAR .gamma.) expression and/or increases its binding affinity to its DNA binding site. The process can further include isolating the adipocytes from remaining hMSCs. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6709864 | | Application Number: | US2000000537003 | | Date Filed: | 28/03/2000 | | Date Published: | 23/03/2004 | | Assignee: | Osiris Therapeutics, Inc., Baltimore, MD, USA |
|
|
